治疗效果-话题@MedSci

#治疗效果#

449篇内容 | 2763人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1894019, encodeId=d1d91894019cd, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案, objectType=article, longId=123207, objectId=4dfc12320e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dfc12320e42, replyNumber=0, likeNumber=16, createdTime=2018-02-20, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dfc12320e42, moduleTitle=【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dfc12320e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893996, encodeId=de5118939968a, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？, objectType=article, longId=111587, objectId=92c111158e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c111158e42, replyNumber=0, likeNumber=71, createdTime=2018-03-20, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c111158e42, moduleTitle=Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c111158e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893953, encodeId=3f651893953f4, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=JCO：太极拳及认知行为治疗对乳腺癌患者失眠治疗效果比较, objectType=article, longId=99167, objectId=d3a39916ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a39916ebf, replyNumber=0, likeNumber=88, createdTime=2017-10-29, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a39916ebf, moduleTitle=JCO：太极拳及认知行为治疗对乳腺癌患者失眠治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a39916ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894010, encodeId=4cd01894010f7, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Diabetes Care：糖尿病合并缺血性下肢溃疡患者采用高压氧治疗效果如何？, objectType=article, longId=117875, objectId=d25611e8751d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d25611e8751d, replyNumber=0, likeNumber=64, createdTime=2018-01-24, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d25611e8751d, moduleTitle=Diabetes Care：糖尿病合并缺血性下肢溃疡患者采用高压氧治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d25611e8751d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894036, encodeId=34c2189403617, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果, objectType=article, longId=129002, objectId=6d3e1290027e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d3e1290027e, replyNumber=0, likeNumber=68, createdTime=2018-08-23, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d3e1290027e, moduleTitle=N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d3e1290027e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894043, encodeId=c064189404343, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Metabolism：2型糖尿病患者采用二甲双胍联合二肽基肽酶-4抑制剂或二甲双胍联合磺脲类治疗效果分析！, objectType=article, longId=132209, objectId=f49e1322098f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49e1322098f, replyNumber=0, likeNumber=78, createdTime=2018-12-03, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49e1322098f, moduleTitle=Metabolism：2型糖尿病患者采用二甲双胍联合二肽基肽酶-4抑制剂或二甲双胍联合磺脲类治疗效果分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49e1322098f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894004, encodeId=25001894004a0, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Clin Cancer Res：简单血检预知癌症治疗效果, objectType=article, longId=115123, objectId=e8be11512361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8be11512361, replyNumber=0, likeNumber=73, createdTime=2017-11-03, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8be11512361, moduleTitle=Clin Cancer Res：简单血检预知癌症治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8be11512361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894029, encodeId=0baa18940293d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Circ: Cardiovasc Inte：药物涂层球囊的治疗效果在股腘动脉中可持续3年, objectType=article, longId=126441, objectId=36bf12644120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36bf12644120, replyNumber=0, likeNumber=60, createdTime=2018-12-19, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36bf12644120, moduleTitle=Circ: Cardiovasc Inte：药物涂层球囊的治疗效果在股腘动脉中可持续3年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36bf12644120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893951, encodeId=9dc6189395126, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=JAMA Ophthalmol：阿托品对儿童近视治疗效果及不良反应, objectType=article, longId=98772, objectId=2d4498e7216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d4498e7216, replyNumber=0, likeNumber=65, createdTime=2017-10-20, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d4498e7216, moduleTitle=JAMA Ophthalmol：阿托品对儿童近视治疗效果及不良反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d4498e7216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893997, encodeId=8882189399e0a, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Immunity：增加血通量可使免疫治疗效果倍增！, objectType=article, longId=112372, objectId=119b1123e216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119b1123e216, replyNumber=0, likeNumber=55, createdTime=2017-12-08, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119b1123e216, moduleTitle=Immunity：增加血通量可使免疫治疗效果倍增！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119b1123e216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894020, encodeId=13161894020e8, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=专家谈肺癌早诊早治：相差1厘米治疗效果大不同, objectType=article, longId=124530, objectId=fc701245304b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc701245304b, replyNumber=0, likeNumber=138, createdTime=2018-01-06, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc701245304b, moduleTitle=专家谈肺癌早诊早治：相差1厘米治疗效果大不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc701245304b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893952, encodeId=607818939527a, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Nursing studies：吸氧治疗并不会改善血氧饱和度正常的急性心肌梗死患者的治疗效果, objectType=article, longId=98886, objectId=524f9888610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=524f9888610, replyNumber=0, likeNumber=67, createdTime=2018-03-17, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=524f9888610, moduleTitle=Nursing studies：吸氧治疗并不会改善血氧饱和度正常的急性心肌梗死患者的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=524f9888610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893983, encodeId=f138189398366, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Blood：Moxetumomab Pasudotox对儿童难治性/复发ALL的治疗效果和安全性。, objectType=article, longId=108401, objectId=2a67108401bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a67108401bb, replyNumber=0, likeNumber=84, createdTime=2018-02-14, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a67108401bb, moduleTitle=Blood：Moxetumomab Pasudotox对儿童难治性/复发ALL的治疗效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a67108401bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893977, encodeId=537418939e786, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Nat Commun：研究揭示膀胱癌治疗效果不佳的重要原因！, objectType=article, longId=106563, objectId=e4a11065633f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4a11065633f, replyNumber=0, likeNumber=56, createdTime=2018-05-27, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4a11065633f, moduleTitle=Nat Commun：研究揭示膀胱癌治疗效果不佳的重要原因！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4a11065633f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894018, encodeId=e6cc189401859, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=J Clin Oncol：晚期癌症患者出院后在哪里进行过渡治疗效果更好？, objectType=article, longId=122399, objectId=e73712239920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73712239920, replyNumber=0, likeNumber=105, createdTime=2018-07-17, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73712239920, moduleTitle=J Clin Oncol：晚期癌症患者出院后在哪里进行过渡治疗效果更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e73712239920)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894031, encodeId=c6dc18940313d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Lancet Oncol：Prexasertib，细胞周期检查点激酶1和激酶2抑制剂，用于高级别浆液性卵巢癌的治疗效果和安全性评估。, objectType=article, longId=126820, objectId=fd5612682002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5612682002, replyNumber=0, likeNumber=49, createdTime=2018-12-24, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5612682002, moduleTitle=Lancet Oncol：Prexasertib，细胞周期检查点激酶1和激酶2抑制剂，用于高级别浆液性卵巢癌的治疗效果和安全性评估。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5612682002)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893950, encodeId=9e8918939509f, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=生存分析和Cox回归中，生存曲线最后交叉，如何衡量治疗效果？, objectType=article, longId=98611, objectId=b39a98611de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b39a98611de, replyNumber=0, likeNumber=55, createdTime=2017-11-10, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b39a98611de, moduleTitle=生存分析和Cox回归中，生存曲线最后交叉，如何衡量治疗效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b39a98611de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894002, encodeId=0e6b189400296, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=CLIN CANCER RES：循环肿瘤DNA早期改变可以作为转移性结直肠癌患者治疗效果的标志, objectType=article, longId=113723, objectId=303c113e237a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=303c113e237a, replyNumber=0, likeNumber=97, createdTime=2018-03-22, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=303c113e237a, moduleTitle=CLIN CANCER RES：循环肿瘤DNA早期改变可以作为转移性结直肠癌患者治疗效果的标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=303c113e237a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893944, encodeId=7f4118939445c, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=Clin Cancer Res：“疫苗+化疗”组合拳：脑癌治疗效果翻一番，展现新希望！, objectType=article, longId=96168, objectId=cf8696168a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8696168a6, replyNumber=0, likeNumber=74, createdTime=2017-08-19, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8696168a6, moduleTitle=Clin Cancer Res：“疫苗+化疗”组合拳：脑癌治疗效果翻一番，展现新希望！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf8696168a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1894001, encodeId=560a18940014d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, objectTitle=JAD：大规模研究：睡眠障碍影响双相障碍的治疗效果, objectType=article, longId=113571, objectId=3f611135e1db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f611135e1db, replyNumber=0, likeNumber=84, createdTime=2018-03-07, rootId=0, userName=jxrzshh, userId=373a131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f611135e1db, moduleTitle=JAD：大规模研究：睡眠障碍影响双相障碍的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f611135e1db)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗效果

2020-05-29

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

【2017 ASH】Brentuximab Vedotin对CD30+皮肤T细胞淋巴瘤的治疗效果显著优于甲氨蝶呤或贝沙罗汀标准方案

2018-02-20

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？

2018-03-20

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

JCO：太极拳及认知行为治疗对乳腺癌患者失眠治疗效果比较

2017-10-29

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Diabetes Care：糖尿病合并缺血性下肢溃疡患者采用高压氧治疗效果如何？

2018-01-24

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

N Engl J Med：Glecaprevir-Pibrentasvir治疗HCV基因1或3型患者，可达到很好的治疗效果

2018-08-23

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Metabolism：2型糖尿病患者采用二甲双胍联合二肽基肽酶-4抑制剂或二甲双胍联合磺脲类治疗效果分析！

2018-12-03

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Clin Cancer Res：简单血检预知癌症治疗效果

2017-11-03

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Circ: Cardiovasc Inte：药物涂层球囊的治疗效果在股腘动脉中可持续3年

2018-12-19

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

JAMA Ophthalmol：阿托品对儿童近视治疗效果及不良反应

2017-10-20

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Immunity：增加血通量可使免疫治疗效果倍增！

2017-12-08

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

专家谈肺癌早诊早治：相差1厘米治疗效果大不同

2018-01-06

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Nursing studies：吸氧治疗并不会改善血氧饱和度正常的急性心肌梗死患者的治疗效果

2018-03-17

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Blood：Moxetumomab Pasudotox对儿童难治性/复发ALL的治疗效果和安全性。

2018-02-14

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Nat Commun：研究揭示膀胱癌治疗效果不佳的重要原因！

2018-05-27

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

J Clin Oncol：晚期癌症患者出院后在哪里进行过渡治疗效果更好？

2018-07-17

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Lancet Oncol：Prexasertib，细胞周期检查点激酶1和激酶2抑制剂，用于高级别浆液性卵巢癌的治疗效果和安全性评估。

2018-12-24

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

生存分析和Cox回归中，生存曲线最后交叉，如何衡量治疗效果？

2017-11-10

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

CLIN CANCER RES：循环肿瘤DNA早期改变可以作为转移性结直肠癌患者治疗效果的标志

2018-03-22

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

Clin Cancer Res：“疫苗+化疗”组合拳：脑癌治疗效果翻一番，展现新希望！

2017-08-19

jxrzshh (审核中...)

前往app查看评论内容

#治疗效果#

JAD：大规模研究：睡眠障碍影响双相障碍的治疗效果

2018-03-07

科室
- - 订阅+
  - 更多科室
工具
服务